Skip to main content

Advertisement

SpringerLink
Log in

Prognosis and factors affecting colorectal cancer with ovarian metastasis

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Colorectal cancer is one of the most common malignant tumors. Its incidence has been increasing in recent years, as has the number of cases of ovarian metastasis of colorectal cancer. The prognosis of colorectal cancer with ovarian metastasis is poor, and it is an important cause of death in female patients. A variety of clinicopathological factors were found to be related to the prognosis of patients with colorectal cancer with ovarian metastasis, such as menopausal status, metastasis limited to the pelvis, and tumor differentiation. Tumor genetic characteristics also provide a new perspective for the prognostic evaluation of colorectal cancer with ovarian metastasis. The prognosis of ovarian metastasis is also closely associated with treatment. The major treatment methods are prophylactic oophorectomy, surgical resection of the primary and metastatic lesions, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy and systematic therapy. If feasible, complete surgical resection of the primary and ovarian metastatic macroscopic lesions combined with postoperative chemotherapy might currently be the most effective treatment for improving the prognosis of patients with colorectal cancer with ovarian metastasis. Genetic analysis also provides a theoretical basis for potential targeted therapy and immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Kato MK, Shida D, Yoneoka Y, Yoshida H, Miyasaka N, Kanemitsu Y, Kato T (2020) Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance. Int J Clin Oncol 25(9):1663–1671. https://doi.org/10.1007/s10147-020-01717-7

    Article  CAS  PubMed  Google Scholar 

  3. Stukan M, Alcazar JL, Gebicki J, Epstein E, Liro M, Sufliarska A, Szubert S, Guerriero S, Braicu EI, Szajewski M, Pietrzak-Stukan M, Fischerova D (2019) Ultrasound and clinical preoperative characteristics for discrimination between ovarian metastatic colorectal cancer and primary ovarian cancer: a case-control study. Diagnostics. https://doi.org/10.3390/diagnostics9040210

    Article  PubMed  PubMed Central  Google Scholar 

  4. Byun JH, Ahn JB, Kim SY, Kang JH, Zang DY, Kang SY, Kang MJ, Shim BY, Baek SK, Kim BS, Lee KH, Lee SI, Cho SH, Sohn BS, Kim S, Hwang IG, Nam EM, Seo BG, Oh SC, Lee MA, Lee SC, Hong JH, Park YS (2019) The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study. Korean J Intern Med 34(1):165–177. https://doi.org/10.3904/kjim.2016.348

    Article  CAS  PubMed  Google Scholar 

  5. Association CCCoCMD (2020) Chinese experts consensus on the management of ovarian metastases from colorectal cancer (2020 version). Chin J Colorec Dis 9(2):115–121. https://doi.org/10.3877/cma.j.issn.2095-3224.2020.02.002

    Article  Google Scholar 

  6. McCormick CC, Giuntoli RL 2nd, Gardner GJ, Schulick RD, Judson K, Ronnett BM, Vang R, Bristow RE (2007) The role of cytoreductive surgery for colon cancer metastatic to the ovary. Gynecol Oncol 105(3):791–795. https://doi.org/10.1016/j.ygyno.2007.02.025

    Article  PubMed  Google Scholar 

  7. Grafner H, Alm P, Oscarson J (1983) Prophylactic oophorectomy in colorectal carcinoma. Obstet Gynecol Surv 146(233):226–228

    Google Scholar 

  8. Birnkrant A, Sampson J, Sugarbaker HP (1986) Ovarian metastasis from colorectal cance. Dis Colon Rectum 29:767–771

    Article  CAS  Google Scholar 

  9. Hanna NN, Cohen AM (2004) Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy. Clin Colorectal Cancer 3(4):215–222. https://doi.org/10.3816/CCC.2004.n.002

    Article  PubMed  Google Scholar 

  10. Kim DD, Park IJ, Kim HC, Yu CS, Kim JC (2009) Ovarian metastases from colorectal cancer: a clinicopathological analysis of 103 patients. Colorectal Dis 11(1):32–38. https://doi.org/10.1111/j.1463-1318.2008.01543.x

    Article  PubMed  Google Scholar 

  11. Alberto C, Snchez R, Piniella F, Pescador D, Borobio G, Garca A, Cano C (2014) Management of non-hepatic metastatic disease in colorectal cancer. J Clin Oncol. https://doi.org/10.5772/57487

    Article  Google Scholar 

  12. Segelman J, Floter-Radestad A, Hellborg H, Sjovall A, Martling A (2010) Epidemiology and prognosis of ovarian metastases in colorectal cancer. Br J Surg 97(11):1704–1709. https://doi.org/10.1002/bjs.7196

    Article  CAS  PubMed  Google Scholar 

  13. Karsh J (1951) Secondary malignant disease of the ovaries; a study of 72 autopsies. Am J Obstet Gynecol 61(1):154–160. https://doi.org/10.1016/0002-9378(51)90018-x

    Article  CAS  PubMed  Google Scholar 

  14. Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I (1995) Clinical implications of metastases to the ovary. Gynecol Oncol 59:124–128

    Article  CAS  Google Scholar 

  15. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM (2004) Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 93(1):87–91. https://doi.org/10.1016/j.ygyno.2003.12.039

    Article  PubMed  Google Scholar 

  16. Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Huettner PC, Herzog TJ (2004) Synchronous ovarian metastases at the time of laparotomy for colon cancer. Gynecol Oncol 92(3):851–855. https://doi.org/10.1016/j.ygyno.2003.12.017

    Article  PubMed  Google Scholar 

  17. Jeung YJ, Ok HJ, Kim WG, Kim SH, Lee TH (2015) Krukenberg tumors of gastric origin versus colorectal origin. Obstet Gynecol Sci 58(1):32–39. https://doi.org/10.5468/ogs.2015.58.1.32

    Article  PubMed  PubMed Central  Google Scholar 

  18. Miller BE, Pittman B, Wan JY, Fleming M (1997) Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 66:368–371

    Article  CAS  Google Scholar 

  19. Chung TS, Chang HJ, Jung KH, Park SY, Lim SB, Choi HS, Jeong SY (2009) Role of surgery in the treatment of ovarian metastases from colorectal cancer. J Surg Oncol 100(7):570–574. https://doi.org/10.1002/jso.21382

    Article  PubMed  Google Scholar 

  20. Fujiwara A, Noura S, Ohue M, Shingai T, Yamada T, Miyashiro I, Ohigashi H, Yano M, Ishikawa O, Kamiura S, Tomita Y (2010) Significance of the resection of ovarian metastasis from colorectal cancers. J Surg Oncol 102(6):582–587. https://doi.org/10.1002/jso.21675

    Article  PubMed  Google Scholar 

  21. Ganesh K, Shah RH, Vakiani E, Nash GM, Skottowe HP, Yaeger R, Cercek A, Lincoln A, Tran C, Segal NH, Reidy DL, Varghese A, Epstein AS, Sonoda Y, Chi D, Guillem J, Temple L, Paty P, Hechtman J, Shia J, Weiser M, Aguilar JG, Kemeny N, Berger MF, Saltz L, Stadler ZK (2017) Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer 123(7):1134–1143. https://doi.org/10.1002/cncr.30424

    Article  CAS  PubMed  Google Scholar 

  22. Sekine K, Hamaguchi T, Shoji H, Takashima A, Honma Y, Iwasa S, Kato K, Takahashi K, Kato T, Kanemitsu Y, Boku N (2018) Retrospective analyses of systemic chemotherapy and cytoreductive surgery for patients with ovarian metastases from colorectal cancer: a single-center experience. Oncology 95(4):220–228. https://doi.org/10.1159/000489665

    Article  CAS  PubMed  Google Scholar 

  23. Al-Busaidi IS, Bailey T, Dobbs B, Eglinton TW, Wakeman CJ, Frizelle FA (2018) Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival. ANZ J Surg. https://doi.org/10.1111/ans.14930

    Article  PubMed  Google Scholar 

  24. Bakkers C, van der Meer R, Roumen RM, Lurvink RJ, Lemmens VE, van Erning FN, de Hingh IH (2020) Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study. Int J Colorectal Dis 35(6):1035–1044. https://doi.org/10.1007/s00384-020-03555-5

    Article  CAS  PubMed  Google Scholar 

  25. Regnard JF, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, Baldeyrou P, Levasseur P (1998) Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66(1):214–218. https://doi.org/10.1016/s0003-4975(98)00269-0

    Article  CAS  PubMed  Google Scholar 

  26. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71(12 Suppl):4252–4266. https://doi.org/10.1002/1097-0142(19930615)71:12+%3c4252::aid-cncr2820711815%3e3.0.co;2-6

    Article  CAS  PubMed  Google Scholar 

  27. Headrick JR, Miller DL, Nagorney DM, Allen MS, Deschamps C, Trastek VF, Pairolero PC (2001) Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 71(3):975–979. https://doi.org/10.1016/s0003-4975(00)02522-4

    Article  CAS  PubMed  Google Scholar 

  28. Jiang R, Tang J, Cheng X, Zang RY (2009) Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol 35(1):92–97. https://doi.org/10.1016/j.ejso.2008.05.006

    Article  CAS  PubMed  Google Scholar 

  29. Young-Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM (1998) Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial. Dis Colon Rectum 41(3):277–283. https://doi.org/10.1007/bf02237479

    Article  CAS  PubMed  Google Scholar 

  30. Zhou R, Liu Y, Wang Y, Huo X, Zhu J, Zhang T (2020) Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience. Int J Clin Oncol 25(10):1822–1829. https://doi.org/10.1007/s10147-020-01730-w

    Article  CAS  PubMed  Google Scholar 

  31. Li X, Huang H, Ran L, Fang C, Yu Y, Luo M, Qiu M (2020) Impact of ovarian metastatectomy on survival outcome of colorectal cancer patients with ovarian metastasis: a retrospective study. Cancer Manag Res 12:4493–4501. https://doi.org/10.2147/cmar.s254876

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lee SJ, Lee J, Lim HY, Kang WK, Choi CH, Lee JW, Kim TJ, Kim BG, Bae DS, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS (2010) Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis. Cancer Chemother Pharmacol 66(2):229–235. https://doi.org/10.1007/s00280-009-1150-2

    Article  PubMed  Google Scholar 

  33. Rayson D, Bouttel E, Whiston F, Stitt L (2000) Outcome after ovarian or adnexal metastectomy in metastatic colorecctal carcinoma. J Surg Oncol 75:186–192

    Article  CAS  Google Scholar 

  34. Xu KY, Gao H, Lian ZJ, Ding L, Li M, Gu J (2017) Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases. World J Surg Oncol 15(1):25. https://doi.org/10.1186/s12957-016-1087-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tan KL, Tan WS, Lim JF, Eu KW (2010) Krukenberg tumors of colorectal origin: a dismal outcome—experience of a tertiary center. Int J Colorectal Dis 25(2):233–238. https://doi.org/10.1007/s00384-009-0796-x

    Article  PubMed  Google Scholar 

  36. Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS (2009) Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci 24(1):114–119. https://doi.org/10.3346/jkms.2009.24.1.114

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kir G, Gurbuz A, Karateke A, Kir M (2010) Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma. World J Gastrointest Surg 2(4):109–116. https://doi.org/10.4240/wjgs.v2.i4.109

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kammar PS, Engineer R, Patil PS, Ostwal V, Shylasree TS, Saklani AP (2017) Ovarian metastases of colorectal origin: treatment patterns and factors affecting outcomes. Indian J Surg Oncol 8(4):519–526. https://doi.org/10.1007/s13193-017-0667-9

    Article  PubMed  PubMed Central  Google Scholar 

  39. Iavazzo C, Spiliotis J (2020) Prognostic significance of ovarian metastases (macroscopic or microscopic) in patients with colorectal cancer undergoing cytoreduction followed by HIPEC. Int J Colorectal Dis 35(7):1335–1336. https://doi.org/10.1007/s00384-020-03613-y

    Article  PubMed  Google Scholar 

  40. Christensen TD, Palshof JA, Larsen FO, Poulsen TS, Hogdall E, Pfeiffer P, Jensen BV, Yilmaz MK, Nielsen D (2018) Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer. Acta Oncol 57(8):1057–1062. https://doi.org/10.1080/0284186X.2018.1433322

    Article  CAS  PubMed  Google Scholar 

  41. Mori Y, Nyuya A, Yasui K, Toshima T, Kawai T, Taniguchi F, Kimura K, Inada R, Nishizaki M, Haraga J, Nakamura K, Umeda Y, Kishimoto H, Fujiwara T, Katata Y, Yamaguchi Y, Nagasaka T (2018) Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles. Oncotarget 9(23):16477–16488. https://doi.org/10.18632/oncotarget.24735

    Article  PubMed  PubMed Central  Google Scholar 

  42. Li JL, Lin SH, Chen HQ, Liang LS, Mo XW, Lai H, Zhang J, Xu J, Gao BQ, Feng Y, Lin Y (2019) Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis. BMC Clin Pathol 19:3. https://doi.org/10.1186/s12907-019-0085-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. He WZ, Hu WM, Wang F, Rong YM, Yang L, Xie QK, Yang YZ, Jiang C, Qiu HJ, Lu JB, Zhang B, Ding PR, Xia XJ, Shao JY, Xia LP (2019) Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer. JNCCN 17(10):1174–1183. https://doi.org/10.6004/jnccn.2019.7308

    Article  CAS  PubMed  Google Scholar 

  44. Tai H, Yang Q, Wu Z, Sun S, Cao R, Xi Y, Zhao R, Zhang M, Zhang Z, Xu C (2018) PD-L1 expression predicts a distinct prognosis in Krukenberg tumor with corresponding origins. J Immunol Res 2018:9485285. https://doi.org/10.1155/2018/9485285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. NCCN (2020) NCCN clinical practice guidelines in oncology colon cancer version 4.2020. National Comprehensive Cancer Network, USA

    Google Scholar 

  46. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D’Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Kohne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Osterlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taieb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27(8):1386–1422. https://doi.org/10.1093/annonc/mdw235

    Article  PubMed  Google Scholar 

  47. Omranipour R, Abasahl A (2009) Ovarian metastases in colorectal cancer. Int J Gynecol Cancer 19(9):1524–1528. https://doi.org/10.1111/IGC.0b013e3181a84011

    Article  PubMed  Google Scholar 

  48. Banerjee S, Kapur S, Moran BJ (2005) The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer. Colorectal Dis 7:214–217

    Article  CAS  Google Scholar 

  49. Mehta AM, Bignell MB, Alves S, Dayal SP, Mohamed F, Cecil TD, Moran BJ (2017) Risk of ovarian involvement in advanced colorectal or appendiceal tumors involving the peritoneum. Dis Colon Rectum 60(7):691–696. https://doi.org/10.1097/dcr.0000000000000791

    Article  PubMed  Google Scholar 

  50. Liang J-T, Lai H-S, Wu C-T, Huang K-c, Lee P-H, Shun C-T (2007) Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer. Ann Surg Oncol 14(7):1991–1999. https://doi.org/10.1245/s10434-007-9346-3)

    Article  PubMed  Google Scholar 

  51. Erroi F, Scarpa M, Angriman I, Cecchetto A, Pasetto L, Mollica E, Bettiol M, Ruffolo C, Polese L, Cillo U, D’Amico DF (2007) Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy. J Surg Oncol 96(2):113–117. https://doi.org/10.1002/jso.20803

    Article  PubMed  Google Scholar 

  52. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K (2020) Clinicopathologic characteristics and impact of oophorectomy for ovarian metastases from colorectal cancer. Oncologist 25(7):564–571. https://doi.org/10.1634/theoncologist.2019-0282

    Article  PubMed  PubMed Central  Google Scholar 

  53. Eveno C, Goere D, Dartigues P, Honore C, Dumont F, Tzanis D, Benhaim L, Malka D, Elias D (2013) Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis. Ann Surg Oncol 20(2):491–496. https://doi.org/10.1245/s10434-012-2623-9

    Article  PubMed  Google Scholar 

  54. Ribeiro Gomes J, Belotto M, D’Alpino Peixoto R (2017) The role of surgery for unusual sites of metastases from colorectal cancer: a review of the literature. Eur J Surg Oncol 43(1):15–19. https://doi.org/10.1016/j.ejso.2016.05.019

    Article  CAS  PubMed  Google Scholar 

  55. Bignell MB, Mehta AM, Alves S, Chandrakumaran K, Dayal SP, Mohamed F, Cecil TD, Moran BJ (2018) Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer. Colorectal Dis 20(8):704–710. https://doi.org/10.1111/codi.14057

    Article  CAS  PubMed  Google Scholar 

  56. van Oudheusden TR, Braam HJ, Nienhuijs SW, Wiezer MJ, van Ramshorst B, Luyer P, de Hingh IH (2015) Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol 111(2):237–242. https://doi.org/10.1002/jso.23784

    Article  PubMed  Google Scholar 

  57. Milovanov V, Sardi A, Studeman K, Nieroda C, Sittig M, Gushchin V (2016) The 7th edition of the AJCC staging classification correlates with biologic behavior of mucinous appendiceal tumor with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Ann Surg Oncol. 23(6):1928–1933. https://doi.org/10.1245/s10434-015-5047-5

    Article  PubMed  Google Scholar 

  58. Goere D, Daveau C, Elias D, Boige V, Tomasic G, Bonnet S, Pocard M, Dromain C, Ducreux M, Lasser P, Malka D (2008) The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. Eur J Surg Oncol 34(12):1335–1339. https://doi.org/10.1016/j.ejso.2008.03.010

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology, The Obstetrics and Gynecology Hospital of Fudan University, 419 Fang-xie Road, Shanghai, 200011, People’s Republic of China

    Fangyue Zhou & Jingxin Ding

Authors
  1. Fangyue Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingxin Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jingxin Ding.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Consent for publication

The authors consent for publication.

Ethical standard

The study was performed following all ethical requirements, and it did not contain any human participants or animal subjects.

Research involving human participants and/or animals

This article does not involve human participants or animals.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, F., Ding, J. Prognosis and factors affecting colorectal cancer with ovarian metastasis. Updates Surg 73, 391–398 (2021). https://doi.org/10.1007/s13304-021-00978-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-021-00978-9

Keywords

Search

Navigation